Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision for Rectal Cancer
Led by Larissa University Hospital · Updated on 2025-09-04
44
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
Sponsors
L
Larissa University Hospital
Lead Sponsor
G
General Hospital of Larissa
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the improvement of anorectal and urogenital urinary function as well as postoperative quality of life in patients undergoing Total Mesorectal Excision (TME) for rectal cancer. The study focuses on the effect of intraoperative neuromonitoring of the pelvic autonomous nerves (pIONM) during surgery. Postoperative urogenital and sexual dysfunction and low anterior syndrome (LARS) are common complications after TME, affecting patients' quality of life, and this research aims to assess whether pIONM can help reduce these issues.
Participants will be randomly assigned to one of two groups. The experimental group will receive intraoperative neuromonitoring using a special device that simultaneously monitors sphincter signals and bladder pressure. Electrodes will be placed in the internal and external anal sphincters and surrounding tissues, and bladder manometry will be performed through a catheter connected to a pressure sensor and monitor. Stimulation parameters include a current of 1-25 milliamps at 30 Hz frequency. The control group will undergo TME without intraoperative neuromonitoring. Both open and laparoscopic surgical approaches will be used depending on the case.
During the study, participants will undergo assessments before surgery and at multiple postoperative time points, including 3 months and up to 24 months. Evaluations include quality of life questionnaires (SF-36), urinary and sexual function questionnaires (IIEF, FSFI, IPSS), and tests measuring bladder capacity, compliance, urinary flow, anal sphincter pressure, and anorectal function. Researchers will monitor operative time, bleeding, complications, hospital discharge time, and local cancer recurrence for up to one year. The primary outcome is the change in quality of life three months after surgery.
CONDITIONS
Brief Title
Intraoperative Neuromonitoring of Pelvic Autonomous Nerve Plexus During Total Mesorectal Excision
Who Can Participate
Age: 18Years - 90Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Histologically confirmed rectal cancer
Scheduled for surgical resection with Total Mesorectal Excision (TME)
Age less than 90 years
Signed informed consent form
You will not qualify if you...
Emergency operation
Presence of pacemaker
Partial mesorectal excision instead of total
Sepsis or systemic infection
Physical or mental impairment
Pregnancy or nursing
Insufficient preoperative data for urogenital or anorectal function
Lack of compliance with the research process
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Surgery day and hospital stay up to 15 days postoperatively
Participants undergo total mesorectal excision (TME) surgery, with or without intraoperative neuromonitoring of the pelvic autonomous nerve plexus. During surgery, special monitoring devices may be used to map nerve function. Immediate post-operative care follows surgery.
1 surgical visit plus hospital stay and assessments until discharge
Post-operative Follow-up
Duration - Up to 24 months postoperatively
Participants are monitored for recovery and complications after surgery. Follow-up includes assessments of quality of life, urogenital and anorectal function, and other health measures at multiple timepoints up to 24 months after surgery.
Visits at 2, 3, 6, 12, and 24 months postoperatively
Continuous intraoperative monitoring of autonomic nerves during low anterior rectal resection: an innovative approach for observation of functional nerve integrity in pelvic surgery.
Risk Factor Analysis for Newly Developed Urogenital Dysfunction after Total Mesorectal Excision and Impact of Pelvic Intraoperative Neuromonitoring-a Prospective 2-Year Follow-Up Study.
Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial.
Christian Wallner, Marilyne M Lange, Bert A Bonsing...
Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trial.
Online signal processing of internal anal sphincter activity during pelvic autonomic nerve stimulation: a new method to improve the reliability of intra-operative neuromonitoring signals.